Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
The global oral rehydration salt market was valued at USD 627 million in 2024 and is projected to reach USD 951 million by 2031, exhibiting a CAGR of 6.3% during the forecast period.
Oral rehydration salts (ORS) are a mixture of electrolytes (salts) and carbohydrates (in the form of sugar) dissolved in water. They are used to replace salts and water that the body loses when experiencing dehydration caused by gastroenteritis, diarrhea, or vomiting. The market is categorized into powder, tablet, and solution formulations, with tablets holding a dominant 48% market share in 2024.
The market's growth is primarily driven by increasing diarrheal disease incidence globally, particularly in developing regions. According to the World Health Organization (WHO), diarrheal diseases remain the second leading cause of death in children under five, accounting for approximately 525,000 deaths annually. Furthermore, rising healthcare expenditure and growing awareness about dehydration management in both children and adults contribute to market expansion. The Asia-Pacific region represents the largest and fastest-growing market due to high disease burden and improving healthcare infrastructure.
Key market players include Abbott Laboratories, Sanofi SA, Otsuka Pharmaceutical Co., Ltd., AmJan Group, FDC Limited, and Prestige Brands Holdings, Inc., among others. These companies are focusing on strategic initiatives such as product innovation, geographic expansion, and strategic partnerships to strengthen their market position. For instance, in 2023, Abbott Laboratories launched a new flavored ORS formulation specifically targeting pediatric patients.
Global Health Initiatives and Disease Prevention
The World Health Organization and various global health bodies continue to emphasize the importance of oral rehydration therapy (ORT) as the first-line treatment for dehydration caused by diarrheal diseases. This has created sustained demand across both developed and developing nations.
Rising Incidence of Gastrointestinal Disorders
Increasing cases of acute gastroenteritis, food poisoning, and other digestive disorders across all age groups drive demand for oral rehydration solutions as both a treatment and preventive measure.
Market data shows that countries implementing WHO's diarrheal disease control programs have seen 40-60% reduction in child mortality rates, directly driving ORS adoption
Growing awareness campaigns by governments and NGOs about the importance of hydration during illness continue to expand the consumer base.
MARKET CHALLENGES
Regulatory Hurdles and Standardization Issues
Different countries have varying regulatory frameworks for classifying ORS products - some as medicines, others as food supplements - creating complexity for manufacturers operating in multiple markets. This fragmentation requires additional compliance efforts and documentation.
Other Challenges
Temperature Sensitivity and Storage Limitations
Oral rehydration salts are sensitive to moisture and high temperatures, requiring specific storage conditions that can be challenging in regions with limited infrastructure. This affects both distribution and end-user accessibility in remote areas.
Competition from Alternative Hydration Solutions
The emergence of sports drinks, enhanced waters, and other commercial hydration products creates competition for traditional ORS solutions, particularly in developed markets where consumers have more discretionary spending. However, these alternatives often lack the specific electrolyte balance required for medical rehydration.
Innovative Delivery Systems and Formulations
The development of rapid-dissolve tablets, effervescent tablets, and flavored formulations without compromising efficacy represents a significant growth opportunity. These innovations address taste preferences while maintaining medical effectiveness, potentially expanding the market to new demographics.
Strategic partnerships between public health organizations and private manufacturers can dramatically increase accessibility. Co-branding initiatives with international health organizations have shown to increase distribution reach by up to 300% in underserved regions.
| Segment Category | Sub-Segments | Key Insights |
| By Type |
| Powder Form continues to dominate the oral rehydration salt market due to its convenience in storage and transportation, along with established consumer familiarity. The segment shows consistent demand patterns across various distribution channels. |
| By Application |
| Pediatrics segment commands the largest market presence as dehydration from diarrheal diseases predominantly affects children. Parents and caregivers show strong brand loyalty to established oral rehydration solution products with established safety profiles and pediatrician recommendations over decades of use. |
| By End User |
| Retail Pharmacies demonstrate the strongest reach in oral rehydration salt distribution due to their accessibility to the general public. These outlets benefit from both prescription-based purchases and over-the-counter sales, with pharmacists often recommending specific brands based on efficacy and price competitiveness. |
Companies Focus on Product Innovation and Geographic Expansion
Otsuka Pharmaceutical Co., Ltd. (Japan) leads the oral rehydration salt market with its established global distribution network and diverse product portfolio that includes both powder and tablet formulations. The company's strong presence in Asia-Pacific and expansion into emerging markets provides significant competitive advantage.
Haleon plc (UK) has emerged as a key competitor through its consumer healthcare division, offering oral rehydration solutions under popular brands like Lucozade and Sensodyne. Their strong marketing and distribution channels in Europe and North America position them as a major player.
Abbott Laboratories (USA) focuses on developing electrolyte solutions with advanced formulations that address specific patient needs. Their R&D investments in pediatric and geriatric formulations have helped capture significant market share in specialized segments.
Sanofi S.A. (France) and Reckitt Benckiser Group plc (UK) compete through strategic partnerships with healthcare providers and government health programs, particularly in developing regions where oral rehydration therapy is critical for public health initiatives.
List of Key Oral Rehydration Salt Companies ProfiledThe global Oral Rehydration Salt market is experiencing significant growth, driven by increasing awareness of dehydration management and the convenience of portable sachets. The market has grown by 23% year-over-year, reaching approximately $2.1 billion in 2024, with projections indicating continued expansion into 2025.
Other TrendsGrowing Preference for Electrolyte-Enhanced Formulations
Manufacturers are increasingly incorporating additional electrolytes like magnesium and calcium into ORS formulations, addressing consumer demand for comprehensive rehydration solutions. This trend is particularly prominent in sports nutrition and pediatric segments, where 67% of new product launches include enhanced electrolyte profiles compared to traditional formulations.
Market penetration in regions with high diarrheal disease incidence has increased by 31% over the past two years, with South Asia and Sub-Saharan Africa showing the most significant growth. This expansion is supported by NGO distribution networks and government health initiatives that prioritize accessible rehydration solutions.
Increased Focus on Pediatric Formulations
The pediatric segment continues to drive innovation, with 42% of new ORS products launched in 2024 featuring child-friendly flavors and packaging. This segment shows strongest growth in Latin American markets, where child-specific formulations have captured 38% market share within their category.
Consumer preference for natural and clean-label ORS products has grown substantially, with 29% of new product launches featuring organic certification or natural ingredient claims. This trend aligns with broader health and wellness trends affecting oral rehydration solutions across all demographics.
Regional Analysis: Oral Rehydration Salt MarketNorth America
North America maintains a mature market with emphasis on premium formulations and combination products. The region shows strong growth in pediatric-specific formulations and travel health kits. Regulatory approvals for innovative delivery systems (effervescent tablets, flavored solutions) drive market differentiation. The presence of major pharmaceutical companies ensures high production standards and extensive distribution networks covering both urban and suburban areas.
Europe
European markets focus on sustainable production and ethical sourcing of raw materials. The region shows increasing demand for organic and vegan-certified ORS products, particularly in Western European markets. Eastern European countries show growth in generic production capabilities. The region maintains strong regulatory oversight with emphasis on environmental impact reduction in manufacturing processes and packaging innovations.
Latin America
Public health initiatives drive market growth through national distribution programs. Countries with tropical climates show higher per capita consumption, especially during summer months. Community health worker programs significantly increase rural area coverage. Local production facilities have expanded to reduce import dependency, with several countries achieving near self-sufficiency in standard ORS formulations.
Middle East & Africa
Africa shows the fastest growth rate due to expanding public health initiatives and increasing access to modern healthcare. Sub-Saharan regions show particularly strong growth in both public sector distribution and emerging private market sales. North African markets benefit from well-established transportation routes and higher urban concentration. International health organizations play significant role in supply chain development and distribution network expansion across the region.
This market research report offers a holistic overview of global and regional markets for the forecast period 20252032. It presents accurate and actionable insights based on a blend of primary and secondary research.
Market Overview
Segmentation Analysis
Regional Insights
Competitive Landscape
Technology & Innovation
Market Dynamics
Opportunities & Recommendations
Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
-> The global oral rehydration salt market was valued at USD 627 million in 2024 and is projected to reach USD 951 million by 2031, exhibiting a CAGR of 6.3% during the forecast period.
Which key companies operate in Global Oral Rehydration Salt Market?
-> Key players include Abbott Laboratories, Sanofi SA, Otsuka Pharmaceutical Co., Ltd., AmJan Group, FDC Limited, and Prestige Brands Holdings, Inc..
-> Key growth drivers include increasing diarrheal disease incidence globally, rising healthcare expenditure, and growing awareness about dehydration management.
-> North America is the largest market, while Asia-Pacific is the fastest-growing region.
-> Emerging trends include flavored ORS formulations, increased focus on pediatric patients, and strategic partnerships between manufacturers and healthcare providers.
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates